NASDAQ:LRMR | Free Cash Flow | Larimar Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$44.61M
2025-12-31$0.00
2025-03-31-$26.54M$49,000.00-$26.59M
2024-12-31-$21.82M$179,000.00-$21.99M
2024-03-31-$10.41M
2023-12-31-$9.34M
2023-03-31-$7.55M
2022-12-31-$6.67M$0.00-$6.67M
2022-03-31-$7.53M
2021-12-31-$7.92M$9,000.00-$7.93M
2021-03-31-$11.21M
2020-12-31-$9.86M-$1,000.00-$9.86M
2020-03-31-$8.92M$58,000.00-$8.98M
2019-12-31-$7.91M$50,000.00-$7.96M
2019-03-31-$12.47M$2,000.00-$12.47M
2018-12-31-$11.83M$12,000.00-$11.85M
2018-03-31-$13.27M$1,000.00-$13.27M
2017-12-31-$9.84M$27,000.00-$9.86M
2017-03-31-$11.68M$10,000.00-$11.69M
2016-12-31-$8.67M$0.00-$8.67M
2016-03-31-$17.76M$400,000.00-$18.16M
2015-12-31-$17.94M$371,000.00-$18.32M
2015-03-31-$11.09M$27,000.00-$11.11M
2014-12-31-$11.71M$16,000.00-$11.73M
2014-03-31-$4.02M$5,000.00-$4.03M
2013-12-31-$4.13M$8,000.00-$4.14M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$113.2M$91,000.00-$113.29M
2024-12-31-$70.76M$515,000.00-$71.28M
2023-12-31-$33.46M$164,000.00-$33.62M
2022-12-31-$27.57M$100,000.00-$27.67M
2021-12-31-$42.11M$333,000.00-$42.44M
2020-12-31-$42.2M$62,000.00-$42.26M
2019-12-31-$22.7M$83,000.00-$22.78M
2018-12-31-$51.49M$108,000.00-$51.6M
2017-12-31-$43.78M$55,000.00-$43.84M
2016-12-31-$51.98M$660,000.00-$52.64M
2015-12-31-$59.55M$595,000.00-$60.15M
2014-12-31-$28.24M$58,000.00-$28.3M
2013-12-31-$15M$17,000.00-$15.02M
2012-12-31-$13.59M$2,000.00-$13.59M